BTB Korea한국비티비
219750 · KOSDAQ · ₩219750 · 한국비티비
- Market cap
- ₩34B
- Enterprise value
- ₩44B
- P/E
- —
- P/B
- 1.7×
- Dividend yield
- 0.0%
- ROE
- −31.9%
- Net margin
- −23.4%
Trailing 12 months from filed financial statements, as of H1 2026. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.
52-week range−54.6% from the high
₩1,502Today: ₩2,425 – ₩2,630₩5,765
Returns
- 1W+7.4%
- 1M+61.3%
- 3M+37.2%
- 6M−37.6%
- YTD−39.3%
- 1Y−48.7%
- Volume today
- 40,645
- 0.8× the 20-day average
- Traded today
- ₩102M
- Listed shares
- 13,085,377
- EPS (12 months)
- −₩481
- Earnings yield −18.4%
Upcoming dates
Full calendar →🎁 Gift this stock
Send a friend ₩100,000 of paper money in this stock. They get it when they join.
Signals
Quiet- BuzzQuietBuzz 41 of 100 (50 is a normal day for this stock).
- MomentumStrong61.7% over the last month; the price is above its 20-day average.
Signals describe activity, not recommendations. Not financial advice.
BTB Korea stock overview
BTB Korea (한국비티비, KRX: 219750) is listed on KOSDAQ, in the Medical & precision devices sector. Korea BTB operates in two divisions: a medical device business that develops, manufactures and sells beauty and anti-aging devices, including professional aesthetic equipment for hospitals and clinics and home beauty devices, and a bio division that distributes research reagents, consumables and lab equipment imported from global bioscience partners to universities, research institutes, hospitals and pharmaceutical companies. Its shares closed at ₩2,620 on Oct 27, 2026, up 0.58% on the day, giving it a market value of ₩34B.
Key facts
- Market cap
- ₩34B
- Sector
- Medical & precision devices
- Latest price change
- +0.58%
- As of
- Oct 27, 2026
- Main business
- Korea BTB operates in two divisions: a medical device business that develops, manufactures and sells beauty and anti-aging devices, including professional aesthetic equipment for hospitals and clinics and home beauty devices, and a bio division that distributes research reagents, consumables and lab equipment imported from global bioscience partners to universities, research institutes, hospitals and pharmaceutical companies.
Quick answers about BTB Korea
- What does BTB Korea do?
- Korea BTB operates in two divisions: a medical device business that develops, manufactures and sells beauty and anti-aging devices, including professional aesthetic equipment for hospitals and clinics and home beauty devices, and a bio division that distributes research reagents, consumables and lab equipment imported from global bioscience partners to universities, research institutes, hospitals and pharmaceutical companies. The company was founded in 1999 and merged with Dongin Biotech in 2024. Its products are sold domestically and in overseas markets, including Southeast Asia, through direct sales, distributors and dealers.
- What is the market cap of BTB Korea?
- The market capitalisation of BTB Korea was ₩34B at the close on Oct 27, 2026.
- Who are the largest shareholders of BTB Korea?
- According to the latest official filings, the largest reported holders are Hanmi BNC (81.24%, as of Jul 27, 2026); Choi Wan-gyu (1.21%, as of Jul 27, 2026); Bae Byeong-hun (0.06%, as of Jul 6, 2026).
- When is the next earnings report from BTB Korea?
- Korean companies rarely announce results dates in advance. Based on when BTB Korea filed the same report in past years, its next 3q results is expected around Nov 14, 2026.
Company profile
Korea BTB operates in two divisions: a medical device business that develops, manufactures and sells beauty and anti-aging devices, including professional aesthetic equipment for hospitals and clinics and home beauty devices, and a bio division that distributes research reagents, consumables and lab equipment imported from global bioscience partners to universities, research institutes, hospitals and pharmaceutical companies. The company was founded in 1999 and merged with Dongin Biotech in 2024. Its products are sold domestically and in overseas markets, including Southeast Asia, through direct sales, distributors and dealers.
Written by AI from the company's latest annual report.
- Korean name
- 한국비티비
- Themes
- Medical devices
- CEO
- 최완규
- Founded
- Feb 1999
- Listed
- Sep 2018
- Listed shares
- 13,085,377
- Fiscal year ends
- Month 12
- Website
- btbkorea.kr
Similar companies
- TSE131290 · ₩2.9T₩260,000+7.88%
- Kctech281820 · ₩1.8T₩91,900+6.37%
- Classys214150 · ₩1.7T₩26,500−2.57%
- Park Systems140860 · ₩1.6T₩225,500+1.12%
- Curiox Biosystems445680 · ₩1.1T₩62,300+6.13%
- DI003160 · ₩1.1T₩37,800+4.71%
- Seers458870 · ₩1T₩26,300−5.57%
- LivsMed491000 · ₩937B₩37,100+1.50%
Recent filings
See all- Added attachment: Half-year report (Jun 2026)Aug 14, 2026
- 5%+ holding reportJul 27, 2026
- Insider shareholding reportJul 27, 2026
- Insider shareholding reportJul 6, 2026
- Insider shareholding reportJul 6, 2026
Titles in Korean until English translations are added.
Also known as: BTB Korea / 한국비티비 / 219750 / KRX:219750
Source: KRX statistical information